Looking down their nose at you : GameStop frenzy showed a fresh contempt for hedge funds. Why do Americans hate them? Jessica Menton, USA TODAY
Replay Video UP NEXT
In the middle of a pandemic and slow economic recovery, Americans think they’ve identified their Wall Street villain: hedge funds.
Their nemesis is summed up in a few searing images: a hedge fund manager who makes millions betting that the subprime mortgage market will collapse, without warning them. Or another relaxing on a yacht as the economy tanks.
Years of anger culminated late last month when a group of angry small-time investors on Reddit took on a few of those firms in the GameStop “short squeeze” frenzy. That spurred millions of others to join in, as their effort to drive up the price of a stock perceived as undervalued soon shifted to a campaign to “Stick it to Wall Street. They used the squeeze to rally the share price and make profits for themselves while forc
(2)
EDISON, NJ / ACCESSWIRE / February 10, 2021 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA)( Hepion ), a clinical stage biopharmaceutical company focused on Artificial Intelligence ( AI )-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis ( NASH ) and liver disease, today announced the appointment of Todd M. Hobbs, M.D., to the newly created position of Chief Medical Officer ( CMO ), effective February 16, 2021.
In this role, Dr. Hobbs will help lead Hepion s engagement with the U.S. Food and Drug Administration ( FDA ), global and national thought leaders, key policymakers, and professional associations.
Dr. Hobbs joins Hepion from Novo Nordisk Inc., one of the world s leading healthcare companies. His 16 years of progressive experience at Novo Nordisk includes positions ranging from field medical affairs leadership at the start of his corporate career through to his most recent role as North American Chief Medical Officer and Vice President.
Coface SA: COFACE SA: Governance evolution - Bernardo Sanchez Incera appointed Chairman of the Board of Directors
COFACE SA: Governance evolution - Bernardo Sanchez Incera appointed Chairman of the Board of Directors
Following the change in the shareholder base and the arrival of Arch Capital Group Ltd. (Arch)
- (NASDAQ: ACGL) -
in Coface s capital, COFACE SA s Board of Directors is evolving. Bernardo Sanchez Incera has been appointed Chairman of the Board of Directors.
The transaction between Natixis and Arch for the sale of a stake in Coface s capital, which was announced on 25 February 2020, has received all the necessary approvals for its closing. As a result, Arch now holds 44.8m shares of Coface, representing 29.5% of the company s capital.
COFACE SA: Governance evolution – Bernardo Sanchez Incera appointed Chairman of the Board of Directors
Paris, 10
COFACE SA: Governance evolution – Bernardo Sanchez Incera appointed Chairman of the Board of Directors
Following the change in the shareholder base and the arrival of Arch Capital Group Ltd. (Arch)
- (NASDAQ: ACGL) -
in Coface s capital, COFACE SA s Board of Directors is evolving. Bernardo Sanchez Incera has been appointed Chairman of the Board of Directors.
The transaction between Natixis and Arch for the sale of a stake in Coface s capital, which was announced on 25 February 2020, has received all the necessary approvals for its closing. As a result, Arch now holds 44.8m shares of Coface, representing 29.5% of the company s capital.
Essential workers in Philly region were 55% more likely to get COVID-19, study finds
Updated Feb 06, 2021;
PHILADELPHIA You’ve seen the “Heroes Work Here” signs thanking health-care providers for risking their lives to do their jobs during the pandemic. You’ve heard about deadly hot spots for workplace exposure to the coronavirus, including meatpacking, food processing, and public transit.
But estimates of the extra risk are iffy. There is no way to know for sure how many COVID-19 infections in the U.S. are directly or indirectly due to jobs, and factors such as testing and masking affect the rates.
Now, researchers at Independence Blue Cross, a major commercial health insurer, and the University of Pennsylvania’s Wharton School of Business have created “a uniquely detailed dataset” to sharpen the picture. They analyzed the impact of Pennsylvania’s increasingly stringent lockdown last year on infection rates for more than 415,000 Blue Cross policyholders and 38